BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16575364)

  • 1. [Contribution of fetal middle cerebral artery peak systolic velocity in the management of non-immune hydrops].
    Oppenheimer A; Jouannic JM; Carbonne B; Brodaty G; Renolleau S; Bénifla JL
    J Gynecol Obstet Biol Reprod (Paris); 2006 Apr; 35(2):176-80. PubMed ID: 16575364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection.
    Cosmi E; Mari G; Delle Chiaie L; Detti L; Akiyama M; Murphy J; Stefos T; Ferguson JE; Hunter D; Hsu CD; Abuhamad A; Bahado-Singh R
    Am J Obstet Gynecol; 2002 Nov; 187(5):1290-3. PubMed ID: 12439522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops.
    Hernandez-Andrade E; Scheier M; Dezerega V; Carmo A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2004 May; 23(5):442-5. PubMed ID: 15133792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops.
    Macé G; Sauvan M; Castaigne V; Moutard ML; Cortey A; Maisonneuve E; Garel C; Dhombres F; Boujenah J; Mailloux A; Carbonne B
    Prenat Diagn; 2014 Nov; 34(11):1023-30. PubMed ID: 24851784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle cerebral artery peak systolic velocity and ductus venosus velocity in the investigation of nonimmune hydrops.
    Borna S; Mirzaie F; Hanthoush-Zadeh S; Khazardoost S; Rahimi-Sharbaf F
    J Clin Ultrasound; 2009 Sep; 37(7):385-8. PubMed ID: 19582828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrops fetalis secondary to parvovirus B19 infections.
    Xu J; Raff TC; Muallem NS; Neubert AG
    J Am Board Fam Pract; 2003; 16(1):63-8. PubMed ID: 12583652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 infection in pregnancy.
    Crane J; Mundle W; Boucoiran I;
    J Obstet Gynaecol Can; 2014 Dec; 36(12):1107-1116. PubMed ID: 25668048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester treatment of fetal anemia secondary to parvovirus B19 infection.
    Kempe A; Rösing B; Berg C; Kamil D; Heep A; Gembruch U; Geipel A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):226-8. PubMed ID: 17252527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal cerebellar hemorrhage in parvovirus-associated non-immune hydrops fetalis.
    Glenn OA; Bianco K; Barkovich AJ; Callen PW; Parer JT
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):769-72. PubMed ID: 17763280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops.
    Kyeong KS; Won HS; Lee MY; Shim JY; Lee PR; Kim A
    Fetal Pediatr Pathol; 2015 Feb; 34(1):49-56. PubMed ID: 25313841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parvovirus B19 in pregnancy: literature review].
    Morel O; Chagnaud S; Laperrelle J; Clément D; Malartic C; Akerman G; Tulpin L; Sitbon M; Barranger E
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1095-104. PubMed ID: 18006356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-immune Hydrops fetalis due to Parvovirus B19 Infection in 2 Extremely Preterm Infants: Perinatal Management and Long-term Neurodevelopmental Outcome.
    Welcker S; Heckmann M
    Z Geburtshilfe Neonatol; 2015 Jun; 219(3):144-7. PubMed ID: 25830498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit.
    Simms RA; Liebling RE; Patel RR; Denbow ML; Abdel-Fattah SA; Soothill PW; Overton TG
    Fetal Diagn Ther; 2009; 25(4):373-8. PubMed ID: 19786782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
    Enders M; Weidner A; Zoellner I; Searle K; Enders G
    Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection.
    Gloning KP; Schramm T; Brusis E; Schwarz T; Roggendorf M
    Behring Inst Mitt; 1990 Aug; (85):79-85. PubMed ID: 2171492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection.
    Delle Chiaie L; Buck G; Grab D; Terinde R
    Ultrasound Obstet Gynecol; 2001 Sep; 18(3):232-6. PubMed ID: 11555452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal management of placental chorioangioma: value of the middle cerebral artery peak systolic velocity.
    Escribano D; Galindo A; Arbués J; Puente JM; De la Fuente P
    Fetal Diagn Ther; 2006; 21(6):489-93. PubMed ID: 16969001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parvovirus B19 in pregnancy.
    Brennand JE; Cameron AD
    Hosp Med; 2000 Feb; 61(2):93-6. PubMed ID: 10748785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrops Fetalis and THE Parvovirus B-19.
    Kontomanolis EN; Fasoulakis Z
    Curr Pediatr Rev; 2018; 14(4):239-252. PubMed ID: 30124157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal parvovirus B19 infection in a twin pregnancy with 1 twin presenting with hydrops fetalis and the other asymptomatic: a case report.
    Leung TN; Leung TY; Chan PK; Fung TY; Lau TK
    J Reprod Med; 2007 May; 52(5):419-21. PubMed ID: 17583243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.